SIRT1 and metabolic dysfunction-associated steatotic liver disease: Another study in HFD-induced NAFLD model showed that LBP effectively decreased hepatic TG accumulation, and its regulatory effect was related to the activation of sirtuin 1 (SIRT1)/liver kinase B1 (LKB1)/AMPK pathway (23).